CLINICAL_TRIALS
trial_result
· 2014-08-21
Clinical Trial Update: SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder [Phase 3]
Summary
Phase 3 trial update for SPD489 in adults with moderate to severe binge eating disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Binge Eating Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-08-21